Clinical Trial Update: Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating dasatinib in combination with bevacizumab for advanced solid tumors has completed. The snippet does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Avastin (bevacizumab)
• Sprycel (dasatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED